ArticleJAC-antimicrobial resistance2026
Healthcare resource utilization and readmission outcomes in patients treated with ceftolozane/tazobactam: real-world insights from the multinational SPECTRA study.
Emre Yücel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.